Hydrogel Applications in the Diagnosis and Treatment of Glioblastoma

Применение гидрогелей в диагностике и лечении глиобластомы
Yunbing Wang, Renming Zhong, S.H. Zhang, Hualong He, Ruiyan Yang, Min Cong Wu, Hong Sheng Xu, Yi Lü, Gaocan Li, Muhammad Rizwan Younis
2024-10-04

Blood-brain barrierGlioblastoma multiformeHydrogel drug deliveryMagnetic resonance imaging contrast agentsTumor microenvironment
Glioblastoma multiforme (GBM), a common malignant neurological tumor, has boundaries indistinguishable from those of normal tissue, making complete surgical removal ineffective. The blood-brain barrier (BBB) further impedes the efficacy of radiotherapy and chemotherapy, leading to suboptimal treatment outcomes and a heightened probability of recurrence. Hydrogels offer multiple advantages for GBM diagnosis and treatment, including overcoming the BBB for improved drug delivery, controlled drug release for long-term efficacy, and enhanced relaxation properties of magnetic resonance imaging (MRI) contrast agents. Hydrogels, with their excellent biocompatibility and customizability, can mimic the in vivo microenvironment, support tumor cell culture, enable drug screening, and facilitate the study of tumor invasion and metastasis. This paper reviews the classification of hydrogels and recent research for the diagnosis and treatment of GBM, including their applications as cell culture platforms and drugs including imaging contrast agents carriers. The mechanisms of drug release from hydrogels and methods to monitor the activity of hydrogel-loaded drugs are also discussed. This review is intended to facilitate a more comprehensive understanding of the current state of GBM research. It offers insights into the design of integrated hydrogel-based GBM diagnosis and treatment with the objective of achieving the desired therapeutic effect and improving the prognosis of GBM.
1
Hydrogel-based delivery systems may enhance MRI diagnosis through improved relaxation properties of encapsulated contrast agents.
2
Hydrogels can improve glioblastoma drug delivery by helping overcome the blood-brain barrier and enabling controlled, sustained release.
3
Integrated hydrogel platforms are proposed as a strategy to combine glioblastoma diagnosis and treatment and potentially improve therapeutic outcomes and prognosis.
4
The review summarizes hydrogel classifications, drug-release mechanisms, activity-monitoring methods, and applications as carriers for therapeutic drugs and imaging agents.
5
Their biocompatibility and tunability allow hydrogels to mimic glioblastoma microenvironments for tumor-cell culture, drug screening, and invasion studies.

Hydrogel-based systems for glioblastoma multiforme diagnosis, treatment, and tumor modeling

Hydrogel-enabled drug delivery, controlled release, MRI contrast enhancement, tumor cell culture, drug screening, and investigation of glioblastoma invasion and metastasis

Publication Details
Publication Date
2024-10-04
Journal
Publisher
ISSN
Cited by
20
Access Type
Author Information
Authors
Yunbing Wang
Renming Zhong
S.H. Zhang
Hualong He
Ruiyan Yang
Min Cong Wu
Hong Sheng Xu
Yi Lü
Gaocan Li
Muhammad Rizwan Younis
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%